# Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

> **NCT03507829** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 263 (actual)

## Conditions studied

- Hyperglycemia

## Interventions

- **DRUG:** Human insulin isophane, Humulin N (Eli Lilly)
- **DRUG:** Standard of care
- **DRUG:** Insulin lispro, Humalog (Eli Lilly) in insulin pump

## Key facts

- **NCT ID:** NCT03507829
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-21
- **Primary completion:** 2018-05-22
- **Final completion:** 2018-05-22
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507829, "Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03507829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*